Ye Kang
277 Yanta West Road
Xi'an, 710061, China
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
USP7 depletion potentiates HIF2α degradation and inhibits clear cell renal cell carcinoma progression.
Journal: Cell death & disease
Published: May 29, 2024
USP29 activation mediated by FUBP1 promotes AURKB stability and oncogenic functions in gastric cancer.
Journal: Cancer cell international
Published: November 16, 2023
The emerging role of USP29 in cancer and other diseases.
Journal: Cell biochemistry and function
Published: November 13, 2023
Identification of USP29 as a key regulator of nucleotide biosynthesis in neuroblastoma through integrative analysis of multi-omics data.
Journal: Cancer biology & therapy
Published: July 18, 2023
Gastric cancer patient-derived organoids model for the therapeutic drug screening.
Journal: Biochimica et biophysica acta. General subjects
Published: May 25, 2023
c-MYC-USP49-BAG2 axis promotes proliferation and chemoresistance of colorectal cancer cells in vitro.
Journal: Biochemical and biophysical research communications
Published: March 20, 2022
Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma.
Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma.
Journal: World journal of gastrointestinal oncology
Published: December 31, 2021
The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism.
Journal: Cancer cell international
Published: October 23, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026